Results 271 to 280 of about 36,829 (314)

Treatment of EPOR-rearranged acute lymphoblastic leukemia with ruxolitinib: case reports and review of the literature. [PDF]

Ann Hematol
Dai Y, Ai Y, Sun S, Tang M, Li J, Gao J, Jiang M.   +6 more
europepmc   +1 more source

Reversal of third-degree AV block with ruxolitinib in VEXAS-associated myocarditis: a case report. [PDF]

Eur Heart J Case Rep
Younas S, Van Beveren J, Bogaert J, Beckers M, Ector J.   +4 more
europepmc   +1 more source

Hyper-activation of STAT3 sustains progression of non-papillary basal-type bladder cancer via FOSL1 regulome [PDF]

, 2019
et al,, Vermi, William
core   +1 more source

STK405759 targets microtubules, modulates STAT1, and enhances ruxolitinib efficacy in myeloproliferative neoplasms. [PDF]

Am J Cancer Res
Rozic G, Makaros Y, Shapira-Netanelov I, Kardash T, Maizels Y, Koman I, Leiba M, Duek A.   +7 more
europepmc   +1 more source

Treatment persistence and overall survival in myelofibrosis treated with ruxolitinib were not affected by the covid-19 pandemic, despite the reduced starting dose: Analysis of AIFA registries. [PDF]

Ann Hematol
Breccia M, Celant S, Palandri F, Passamonti F, Olimpieri PP, Summa V, Guarcello A, Palumbo GA, Pane F, Guglielmelli P, Zinzani P, Corradini P, Russo P.   +12 more
europepmc   +1 more source

Clinical and disease characteristics from REVEAL at time of enrollment (baseline): Prospective observational study of patients with polycythemia vera in the United States [PDF]

, 2018
Boccia, Ralph V, Colucci, Philomena, Grunwald, Michael R, Mesa, Ruben, Oh, Stephen T, Paranagama, Dilan, Parasuraman, Shreekant, Stein, Brady L   +7 more
core   +1 more source

Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Top-Line Results From a 16-Week, Multicenter, Randomized, Double-Blind Study

Matthew Zirwas, Philippa Halden, Zhihong Lai, YuTzu Kuo, Haq Nawaz, Linda Stein Gold   +5 more
openalex   +2 more sources

Treatment of vitiligo with topical ruxolitinib: a narrative review. [PDF]

Drugs Context
Monteiro E Silva G, Mohamed A, Ferreira C, Torres T.   +3 more
europepmc   +1 more source

Topical 1.5% ruxolitinib cream for facial refractory segmental vitiligo: A retrospective single-center study. [PDF]

JAAD Int
Huang H, Duan D, Huang H, Tang X, Zhu C, Zhang Y, Li M, Sheng Y, Xiang L, Cui Y, Zhou Y, Zhang X, Zhang B.   +12 more
europepmc   +1 more source

Successful Treatment of Childhood Nail Lichen Planus with Ruxolitinib Cream: A Case Report. [PDF]

Clin Cosmet Investig Dermatol
Sheng A, Hu W, Xu A.
europepmc   +1 more source